Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Reuven Or
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Anatomy
Living Beings
Concepts & Ideas
Chemicals & Drugs
Sign-in to see full Profile
Network (preview)
114
Slavin, Shimon
79
Nagler, Arnon
66
Naparstek, Elizabeth
50
Shapira, Michael
38
Ackerstein, Aliza
35
Aker, Memet
35
Resnick, Igor
32
Samuel, Simcha
29
Kapelushnik, Joseph
25
Bitan, Menachem
25
Weiss, Lola
23
Breuer, Raphael
21
Elad, Sharon
20
Gesundheit, Benjamin
20
Engelhard, Dan
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Reuven Or (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Stepensky Polina; Or Reuven; Shapira Michael Y; Revel-Vilk Shoshana; Stein Jerry; Resnick Igor B
Second bone marrow transplantation for patients with thalassemia: risks and benefits.
Haematologica 2009;94(9):1329-30.
-
2009: Ben-Dov Iddo Z; Pizov Galina; Ben-Chetrit Eldad; Rubinger Dvora; Or Reuven
Fatal nephrotic syndrome complicating allogeneic stem cell transplantation: a case report.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(9):2946-9.
-
2009: Kedmi Meirav; Resnick Igor B; Dray Liliane; Aker Memet; Samuel Simcha; Gesundheit Benjamin; Slavin Shimon; Or Reuven; Shapira Michael Y
A retrospective review of the outcome after second or subsequent allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(4):483-9.
-
2009: Har-Noy M; Zeira M; Weiss L; Fingerut E; Or R; Slavin S
Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma.
Leukemia research 2009;33(4):525-38.
-
2009: Gesundheit Benjamin; Shapira Michael Y; Resnick Igor B; Amar Avraham; Kristt Don; Dray Lilianne; Budowski Einat; Or Reuven
Successful cell-mediated cytokine-activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantation.
American journal of hematology 2009;84(3):188-90.
-
2009: Shapira M Y; Abdul-Hai A; Resnick I B; Bitan M; Tsirigotis P; Aker M; Gesundheit B; Slavin S; Or R
Alefacept treatment for refractory chronic extensive GVHD.
Bone marrow transplantation 2009;43(4):339-43.
-
2009: Shapira Michael Y; Resnick Igor B; Dray Liliane; Aker Memet; Stepensky Polina; Elad Sharon; Gesundeheidt Benjamin; Samuel Simcha; Or Reuven
A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus.
Cytotherapy 2009;11(1):61-7.
-
2008: Gesundheit Benjamin; Malach Lea; Or Reuven; Hahn Talia
Neuroblastoma Cell Death is Induced by Inorganic Arsenic Trioxide (As(2)O (3)) and Inhibited by a Normal Human Bone Marrow Cell-Derived Factor.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society 2008;1(1):153-7.
-
2008: Gesundheit Benjamin; Lerer Bernard; Budowski Einat; Neuman Tzahi; Gomori John M; Or Reuven
Sudden psychotic symptoms in a 28-year-old male with thymoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4353-5.
-
2008: Gesundheit Benjamin; Or Reuven; Gamliel Chanoch; Rosner Fred; Steinberg Avraham
Treatment of depression by Maimonides (1138-1204): rabbi, physician, and philosopher.
The American journal of psychiatry 2008;165(4):425-8.
-
2008: Resnick Igor B; Tsirigotis Panagiotis D; Shapira Michael Y; Aker Memet; Bitan Menachem; Samuel Simcha; Abdul-Hai Ali; Ackerstein Aliza; Or Reuven; Slavin Shimon
ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(4):409-17.
-
2008: Gesundheit Benjamin; Shapira Michael Y; Maly Alexander; Samuel Simcha; Budowski Einat; Or Reuven
Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion.
Leukemia research 2008;32(3):501-3.
-
2008: Samuel Simcha; Azar Yehudith; Corchia Nataly; Or Reuven
Improved immune function with donor B-cell infusion after semi-allogeneic bone marrow transplantation in mice.
Archives of medical research 2008;39(1):61-8.
-
2008: Bitan M; Or R; Shapira M Y; Resnick I B; Gesundheit B; Ackerstein A; Samuel S; Elad S; Slavin S
Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia.
Bone marrow transplantation 2008;41(1):69-78.
-
2007: Gesundheit Benjamin; Moser Asher; Or Reuven; Klement Giannoula
Successful antiangiogenic therapy for neuroblastoma with thalidomide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5321-4.
-
2007: Tsirigotis P; Sella T; Shapira M Y; Bitan M; Bloom A; Kiselgoff D; Levin M; Libster D; Abdul Hai A; Gesundheit B; Or R; Slavin S; Resnick I
Peliosis hepatis following treatment with androgen-steroids in patients with bone marrow failure syndromes.
Haematologica 2007;92(11):e106-10.
-
2007: Resnick I B; Aker M; Tsirigotis P; Shapira M Y; Abdul-Hai A; Bitan M; Gesundheit B; Amar A; Ackerstein A; Samuel S; Slavin S; Or R
Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
Bone marrow transplantation 2007;40(10):957-64.
-
2007: Shapira Michael Y; Tsirigotis P; Resnick I B; Or R; Abdul-Hai A; Slavin S
Allogeneic hematopoietic stem cell transplantation in the elderly.
Critical reviews in oncology/hematology 2007;64(1):49-63.
-
2007: Gesundheit Benjamin; Zelig Orly; Shapira Michael Y; Ackerstein Aliza; Avgil Meytal; Or Reuven
Complete remission of multiple myeloma after autoimmune hemolytic anemia: possible association with interferon-alpha.
American journal of hematology 2007;82(6):489-92.
-
2007: Weiss Lola; Reich Shoshana; Zeira Michael; Or Reuven; Resnick Igor B; Slavin Shimon; Shapira Michael Y
N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activity.
Transplant immunology 2007;17(3):198-202.
-
2007: Or Reuven; Gesundheit Benjamin; Resnick Igor; Bitan Menachem; Avraham Amar; Avgil Meytal; Sacks Zadok; Shapira Michael Y
Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study.
Transplantation 2007;83(5):577-81.
-
2007: Shapira Michael Y; Hai Ali Abdul; Tsirigotis Panagiotis; Resnick Igor B; Or Reuven; Slavin Shimon
Hematopoietic stem cell therapy for malignant diseases.
Annals of medicine 2007;39(6):465-73.
-
2006: Or R; Hadar E; Bitan M; Resnick I B; Aker M; Ackerstein A; Samuel S; Tsirigotis P; Gesundheit B; Slavin S; Shapira M Y
Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1295-301.
-
2006: Abdul-Hai Ali; Ben-Yehuda Arie; Galsky Haya; Slavin Shimon; Or Reuven
Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice.
Cancer immunology, immunotherapy : CII 2006;55(11):1330-6.
-
2006: Gesundheit Benjamin; Steinberg Avraham; Glick Shimon; Or Reuven; Jotkovitz Alan
Euthanasia: an overview and the jewish perspective.
Cancer investigation 2006;24(6):621-9.
-
2006: Miodosky M; Abdul-Hai A; Tsirigotis P; Or R; Bitan M; Resnick I B; Gesundheit B; Zilberman I; Ioffe L; Leubovic A; Slavin S; Shapira M Y
Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate.
Bone marrow transplantation 2006;38(7):507-11.
-
2006: Bitan M; Or R; Shapira M Y; Aker M; Resnick I B; Ackerstein A; Samuel S; Elad S; Slavin S
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):712-8.
-
2006: Resnick Igor B; Aker Memet; Shapira Michael Y; Tsirigotis Panagiotis D; Bitan Menachem; Abdul-Hai Ali; Samuel Simcha; Ackerstein Aliza; Gesundheit Benjamin; Zilberman Irina; Miron Svetlana; Yoffe Luba; Lvovich Alex; Slavin Shimon; Or Reuven
Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen.
British journal of haematology 2006;133(6):649-54.
-
2006: Elad Sharon; Wexler Alon; Garfunkel Adi A; Shapira Michael Y; Bitan Menachem; Or Reuven
Oral candidiasis prevention in transplantation patients: a comparative study.
Clinical transplantation 2006;20(3):318-24.
-
2006: Gesundheit Benjamin; Or Reuven; Amar Avraham; Filon Dvora; Gail Amir
Gaucher-like cells in beta-thalassemia patient after bone marrow transplantation.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2006;28(4):203-4.
-
2006: Abdul-Hai Ali; Weiss Lola; Slavin Shimon; Or Reuven
Improved survival following induction of GVHD following lipopolysaccharide immunization.
Experimental hematology 2006;34(4):549-53.
-
2006: Elad S; Ackerstein A; Bitan M; Shapira M Y; Resnick I; Gesundheit B; Cohen Y; Diss O; Barak D; Dray L; Or R
A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation.
Bone marrow transplantation 2006;37(8):757-62.
-
2005: Nusair Samir; Or Reuven; Junadi Samer; Amir Gail; Breuer Raphael
Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model.
Chest 2005;128(6):4024-9.
-
2005: Resnick Igor B; Abdul Hai Ali; Shapira Michael Y; Bitan Menachem; Hershkovitz Eli; Schwartz Arie; Ben-Harush Miriam; Or Reuven; Slavin Shimon; Kapelushnik Joseph
Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.
Clinical transplantation 2005;19(6):840-7.
-
2005: Shapira M Y; Resnick I B; Bitan M; Ackerstein A; Tsirigotis P; Gesundheit B; Zilberman I; Miron S; Leubovic A; Slavin S; Or R
Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft-versus-host disease: a preliminary report.
Bone marrow transplantation 2005;36(12):1097-101.
-
2005: Bitan Menachem; Or Reuven; Shapira Michael Y; Resnick Igor B; Ackerstein Aliza; Samuel Simcha; Elad Sharon; Slavin Shimon
Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent.
Haematologica 2005;90(8):1089-95.
-
2005: Bitan Menachem; Shapira Michael Y; Resnick Igor B; Zilberman Irina; Miron Svetlana; Samuel Simcha; Ackerstein Aliza; Elad Sharon; Israel Shosh; Amar Avraham; Fibach Eitan; Or Reuven; Slavin Shimon
Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells.
Experimental hematology 2005;33(6):713-8.
-
2005: Bitan M; Or R; Shapira M Y; Ackerstein A; Samuel S; Slavin S
Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide.
Bone marrow transplantation 2005;35(10):953-8.
-
2005: Shapira Michael Y; Raphaelovich Yisrael; Gilad Leon; Or Reuven; Dumb Avraham J; Ingber Arieh
Treatment of atopic dermatitis with herbal combination of Eleutherococcus, Achillea millefolium, and Lamium album has no advantage over placebo: a double blind, placebo-controlled, randomized trial.
Journal of the American Academy of Dermatology 2005;52(4):691-3.
-
2005: Shapira Michael Y; Hirshfeld Ester; Weiss Lola; Zeira Michael; Kasir Judith; Or Reuven; Resnick Igor B; Slavin Shimon
Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model.
Cancer immunology, immunotherapy : CII 2005;54(4):383-8.
-
2004: Resnick Igor B; Gomori John M; Kiselgoff David; Lossos Alex; Zilberman Irina; Miron Svetlana; Bitan Menachem; Or Reuven; Slavin Shimon; Shapira Michael Y
Spinal epidural lipomatosis following haploidentical allogeneic bone marrow transplantation for non-Hodgkin lymphoma.
Clinical transplantation 2004;18(6):762-5.
-
2004: Or Reuven; Aker Memet; Shapira Michael Yechiel; Resnick Igor; Bitan Menachem; Samuel Simcha; Slavin Shimon
Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products.
Springer seminars in immunopathology 2004;26(1-2):133-42.
-
2004: Bitan Menachem; Or Reuven; Shapira Michael Y; Mador Nurith; Resnick Igor B; Saleh Niveen; Weinberger Klaus M; Samuel Simcha; Schechter Esther; Slavin Shimon; Wolf Dana G
Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):1076-8.
-
2004: Shapira M Y; Resnick I B; Bitan M; Ackerstein A; Samuel S; Elad S; Miron S; Zilberman I; Slavin S; Or R
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients.
Bone marrow transplantation 2004;34(2):155-9.
-
2004: Weiss Lola; Or Reuven; Slavin Shimon; Naparstek Ella; Reich Shoshana; Abdul-Hai Ali
Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells.
Cancer immunology, immunotherapy : CII 2004;53(4):358-62.
-
2004: Bloom Allan I; Shapira Michael Y; Or Reuven; Sasson Talia; Resnick Igor B; Zilberman Irena; Verstandig Anthony; Aker Memet; Slavin Shimon; Muszkat Mordechai
Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial.
Clinical therapeutics 2004;26(3):407-14.
-
2004: Nusair S; Breuer R; Shapira M Y; Berkman N; Or R
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;23(3):440-5.
-
2004: Barkan D; Nusair S; Resnick I B; Bitan M; Segel M J; Or R; Ackerstein A; Samuel S; Breuer R; Shapira M Y
Tube thoracostomy during allogeneic stem cell transplantation does not carry an increased risk for infections or bleeding.
Clinical transplantation 2004;18(1):85-8.
-
2004: Slavin Shimon; Morecki Shoshana; Weiss Lola; Shapira Michael Y; Resnick Igor; Or Reuven
Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside.
Seminars in oncology 2004;31(1):4-21.
-
2003: Segel Michael J; Izbicki Gabriel; Cohen Pazit Y; Or Reuven; Christensen Thomas G; Wallach-Dayan Shulamit B; Breuer Raphael
Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis.
American journal of physiology. Lung cellular and molecular physiology 2003;285(6):L1255-62.
-
2003: Elad S; Or R; Shapira M Y; Haviv A; Galili D; Garfunkel A A; Bitan M; Kaufman E
CO2 laser in oral graft-versus-host disease: a pilot study.
Bone marrow transplantation 2003;32(10):1031-4.
-
2003: Bitan M; Resnick I B; Or R; Rokach A; Laxer U; Ackerstein A; Elad S; Slavin S; Shapira M Y
Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliterans.
American journal of hematology 2003;74(3):182-6.
-
2003: Elad Sharon; Garfunkel Adi A; Or Reuven; Michaeli Eli; Shapira Michael Y; Galili Dan
Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(10):674-7.
-
2003: Gillis Shmuel; Eisenberg Michal E; Shapira Michael Y; Or Reuven
Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation.
The Israel Medical Association journal : IMAJ 2003;5(9):671-3.
-
2003: Shapira M Y; Or R; Resnick I B; Bitan M; Ackerstein A; Samuel S; Elad S; Zilberman I; Miron S; Slavin S
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
Bone marrow transplantation 2003;32(6):557-61.
-
2003: Elad Sharon; Or Reuven; Resnick Igor; Shapira Michael Y
Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(9):665-70.
-
2003: Slavin Shimon; Morecki Shoshana; Weiss Lola; Or Reuven
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.
Critical reviews in oncology/hematology 2003;46(2):139-63.
-
2003: Shapira Michael Y; Kaspler Pavel; Samuel Simcha; Shoshan Shmuel; Or Reuven
Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors.
American journal of hematology 2003;73(1):33-6.
-
2003: Paltiel O; Rubinstein C; Or R; Nagler A; Gordon L; Deutsch L; Polliack A; Naparstek E
Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma.
Bone marrow transplantation 2003;31(7):565-9.
-
2003: Elad Sharon; Or Reuven; Garfunkel Adi A; Shapira Michael Y
Budesonide: a novel treatment for oral chronic graft versus host disease.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2003;95(3):308-11.
-
2003: Weiss L; Abdul-Hai A; Or R; Amir G; Polliack A
Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia.
Bone marrow transplantation 2003;31(1):11-5.
-
2003: Or Reuven; Shapira Michael Y; Resnick Igor; Amar Avraham; Ackerstein Aliza; Samuel Simcha; Aker Memet; Naparstek Elizabeth; Nagler Arnon; Slavin Shimon
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.
Blood 2003;101(2):441-5.
-
2002: Shapira Michael Y; Bloom Allan I; Or Reuven; Sasson Talia; Nagler Arnon; Resnick Igor B; Aker Memet; Zilberman Irina; Slavin Shimon; Verstanding Anthony
Intra-arterial catheter directed therapy for severe graft-versus-host disease.
British journal of haematology 2002;119(3):760-4.
-
2002: Izbicki Gabriel; Or Reuven; Christensen Thomas G; Segel Michael J; Fine Alan; Goldstein Ronald H; Breuer Raphael
Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice.
American journal of physiology. Lung cellular and molecular physiology 2002;283(5):L1110-6.
-
2002: Slavin Shimon; Aker Mehmet; Shapira Michael Y; Panigrahi Soumya; Gabriel Cividalli; Or Reuven
Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2002;27(2):159-66.
-
2002: Tzurel Anat; Segel Michael J; Or Reuven; Goldstein Ronald H; Breuer Raphael
Halofuginone does not reduce fibrosis in bleomycin-induced lung injury.
Life sciences 2002;71(14):1599-606.
-
2002: Nusair S; Amir G; Or R; Breuer R
Invasive airway aspergillosis with new airflow obstruction mimicking post-BMT bronchiolitis obliterans.
Bone marrow transplantation 2002;29(8):711-3.
-
2002: Slavin Shimon; Morecki Shoshana; Weiss Lola; Or Reuven
Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):265-76.
-
2002: Slavin Shimon; Nagler Arnon; Shapira Michael Y; Aker Mehmet; Gabriel Cividalli; Or Reuven
Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation.
Journal of clinical immunology 2002;22(2):64-9.
-
2002: Lossos Izadore S; Or Reuven; Ginzburg Vallery; Christensen Thomas G; Mashriki Yaffa; Breuer Raphael
Cyclosporin A upmodulates bleomycin-induced pulmonary fibrosis in BALB/c mice.
Respiration; international review of thoracic diseases 2002;69(4):344-9.
-
2001: Slavin S; Or R; Aker M; Shapira M Y; Panigrahi S; Symeonidis A; Cividalli G; Nagler A
Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals.
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S79-84.
-
2001: Morecki S; Gelfand Y; Nagler A; Or R; Naparstek E; Varadi G; Engelhard D; Akerstein A; Slavin S
Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
Bone marrow transplantation 2001;28(3):243-9.
-
2001: Slavin S; Nagler A; Aker M; Shapira M Y; Cividalli G; Or R
Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.
Reviews in clinical and experimental hematology 2001;5(2):135-46.
-
2001: Panigrahi S; Nagler A; Or R; Wolf D G; Slavin S; Shapira M Y
Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation.
Bone marrow transplantation 2001;27(6):659-61.
-
2001: Nagler A; Aker M; Or R; Naparstek E; Varadi G; Brautbar C; Slavin S
Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Experimental hematology 2001;29(3):362-70.
-
2001: Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
Bone marrow transplantation 2001;27(2):183-90.
-
2001: Segel M J; Or R; Tzurel A; Lucey E C; Goldstein R H; Izbicki G; Breuer R
All-trans-retinoic acid (ATRA) is of no benefit in bleomycin-induced lung injury.
Pulmonary pharmacology & therapeutics 2001;14(5):403-7.
-
2001: Berkman N; Kremer S; Or R; Lossos I S; Christensen T G; Goldstein R H; Breuer R
Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury.
Respiration; international review of thoracic diseases 2001;68(2):169-77.
-
2000: Nagler A; Ackerstein A; Or R; Naparstek E; Slavin S
Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation.
Experimental hematology 2000;28(11):1225-31.
-
2000: Lossos I S; Izbicki G; Or R; Goldstein R H; Breuer R
The effect of suramin on bleomycin-induced lung injury.
Life sciences 2000;67(23):2873-81.
-
2000: Gur I; Or R; Segel M J; Shriki M; Izbicki G; Breuer R
Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice.
Experimental lung research 2000;26(7):521-34.
-
2000: Nagler A; Or R; Naparstek E; Varadi G; Slavin S
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation.
Experimental hematology 2000;28(9):1096-104.
-
2000: Slavin S; Nagler A; Varadi G; Or R
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
Experimental hematology 2000;28(7):853-7.
-
2000: Slavin S; Or R; Prighozina T; Gurevitch O; Aker M; Panighari S; Shapira M; Nagler A
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.
Bone marrow transplantation 2000;25 Suppl 2():S54-7.
-
2000: Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Bone marrow transplantation 2000;25(10):1021-8.
-
2000: Or R; Weiss L; Amir G; Tejman S; Polliack A
The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine models.
Bone marrow transplantation 2000;25(3):263-6.
-
1999: Rosales F; Naparstek E; Varadi G; Or R; Slavin S; Nagler A
The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia.
Leukemia research 1999;23(10):947-52.
-
1999: Elad S; Garfunkel A A; Enk C D; Galili D; Or R
Ultraviolet B irradiation: a new therapeutic concept for the management of oral manifestations of graft-versus-host disease.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 1999;88(4):444-50.
-
1999: Laxer U; Lossos I S; Gillis S; Or R; Christensen T G; Goldstein R H; Breuer R
The effect of enoxaparin on bleomycin-induced lung injury in mice.
Experimental lung research 1999;25(6):531-41.
-
1999: Nagler A; Ackerstein A; Kapelushnik J; Or R; Naparstek E; Slavin S
Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease.
Bone marrow transplantation 1999;24(3):339-42.
-
1999: Naparstek E; Delukina M; Or R; Nagler A; Kapelushnik J; Varadi G; Strauss N; Cividalli G; Aker M; Brautbar C; Waldmann H; Hale G; Slavin S
Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
Experimental hematology 1999;27(7):1210-8.
-
1999: Chevion S; Or R; Berry E M
The antioxidant status of patients subjected to total body irradiation.
Biochemistry and molecular biology international 1999;47(6):1019-27.
-
1999: Varadi G; Or R; Kapelushnik J; Naparstek E; Nagler A; Brautbar C; Amar A; Kirschbaum M; Samuel S; Slavin S; Siegal T
Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma.
Leukemia & lymphoma 1999;34(1-2):185-90.
-
1999: Rosales F; Peylan-Ramu N; Cividalli G; Varadi G; Or R; Naparstek E; Slavin S; Nagler A
The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
Bone marrow transplantation 1999;23(9):861-5.
-
1999: Elad S; Cohen G; Zylber-Katz E; Findler M; Galili D; Garfunkel A A; Or R
Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1999;28(4):170-2.
-
1999: Ben-Yehuda A; Wirtheim E; Abdul-Hai A; Or R; Slavin S; Babaey S; Friedman G
Activation of the recombination activating gene 1 (RAG-1) transcript in bone marrow of senescent C57BL/6 mice by recombinant interleukin-7.
The journals of gerontology. Series A, Biological sciences and medical sciences 1999;54(4):B143-8.
-
1999: Kremer S; Breuer R; Lossos I S; Berkman N; Christensen T G; Connor M W; Goldstein R H; Or R
Effect of immunomodulators on bleomycin-induced lung injury.
Respiration; international review of thoracic diseases 1999;66(5):455-62.
-
1998: Or R; Abdul-Hai A; Ben-Yehuda A
Reviewing the potential utility of interleukin-7 as a promoter of thymopoiesis and immune recovery.
Cytokines, cellular & molecular therapy 1998;4(4):287-94.
-
1998: Or R; Ackerstein A; Nagler A; Amar A; Naparstek E; Varadi G; Kapelushnik J; Samuel S; Pugatsch T; Brautbar C; Slavin S
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(6):447-53.
-
1998: Nagler A; Finlander R; Or R; Naparstek E; Varadi G; Slavin S
The role of thiotepa in autologous bone marrow transplantation for acute leukemia.
Leukemia research 1998;22(11):991-5.
-
1998: Nagler A; Condiotti R; Nabet C; Naparstek E; Or R; Samuel S; Slavin S
Selective CD4+ T-cell depletion does not prevent graft-versus-host disease.
Transplantation 1998;66(1):138-41.
-
1998: Nagler A; Soni S; Samuel S; Or R
Engraftment following mitoxantrone (Mito) based conditioning for allogeneic bone marrow transplantation (allo-BMT).
Leukemia research 1998;22(3):209-13.
-
1998: Or R; Ackerstein A; Nagler A; Kapelushnik J; Naparstek E; Samuel S; Amar A; Bruatbar C; Slavin S
Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study.
Cytokines, cellular & molecular therapy 1998;4(1):1-6.
-
1998: Elishoov H; Or R; Strauss N; Engelhard D
Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study.
Medicine 1998;77(2):83-101.
-
1998: Aker M; Kapelushnik J; Pugatsch T; Naparstek E; Ben-Neria S; Yehuda O; Amar A; Nagler A; Slavin S; Or R
Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1998;20(2):145-8.
-
1998: Gilon D; Schechter D; Rein A J; Gimmon Z; Or R; Rozenman Y; Slavin S; Gotsman M S; Nagler A
Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation.
American heart journal 1998;135(3):457-62.
-
1998: Or R; Feferman R; Shoshan S
Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs.
Experimental hematology 1998;26(3):217-21.
-
1998: Slavin S; Nagler A; Naparstek E; Kapelushnik Y; Aker M; Cividalli G; Varadi G; Kirschbaum M; Ackerstein A; Samuel S; Amar A; Brautbar C; Ben-Tal O; Eldor A; Or R
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Blood 1998;91(3):756-63.
-
1997: Cohen G; Elad S; Or R; Galili D; Garfunkel A A
The use of tretinoin as oral mucositis prophylaxis in bone marrow transplantation patients: a preliminary study.
Oral diseases 1997;3(4):243-6.
-
1997: Kapelushnik J; Or R; Slavin S; Nagler A
A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia.
Bone marrow transplantation 1997;20(12):1109-10.
-
1997: Elad S; Galili D; Garfunkel A A; Or R
Thalidomide-induced perioral neuropathy.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 1997;84(4):362-4.
-
1997: Ben-Yosef R; Or R; Naparstek E; Kapelushnik J; Samuels S; Slavin S; Nagler A
Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients.
American journal of clinical oncology 1997;20(4):419-23.
-
1997: Toren A; Or R; Ackerstein A; Nagler A
Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT).
Bone marrow transplantation 1997;20(1):67-9.
-
1997: Nagler A; Ackerstein A; Or R; Naparstek E; Slavin S
Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation.
Blood 1997;89(11):3951-9.
-
1997: Bursztyn M; Zelig O; Or R; Nagler A
Isradipine for the prevention of cyclosporine-induced hpertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study.
Transplantation 1997;63(7):1034-6.
-
1997: Abdul-Hai A; Ben-Yehuda A; Weiss L; Friedman G; Zakay-Rones Z; Slavin S; Or R
Interleukin-7-enhanced cytotoxic T lymphocyte activity after viral infection in marrow transplanted mice.
Bone marrow transplantation 1997;19(6):539-43.
-
1997: Zelig O; Goldin E; Okon E; Or R; Alian H; Caspi O; Ben-Yehuda D
Hepatobiliary graft-versus-host disease manifested by common and hepatic biliary duct obstruction.
Digestion 1997;58(5):494-7.
-
1997: Ben Yehuda A; Lossos I S; Or R; Ben Chetrit E; Goldstein R H; Conner M W; Breuer R
Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters.
Pulmonary pharmacology & therapeutics 1997;10(1):61-5.
-
1997: Or R; Nagler A; Elad S; Naparstek E; Schechter D
Noncardiogenic pulmonary congestion following bone marrow transplantation.
Respiration; international review of thoracic diseases 1997;64(2):170-2.
-
1996: Kapelushnik J; Nagler A; Or R; Naparstek E; Ackerstein A; Samuel S; Morecki S; Nabet C; Slavin S
Activated allogeneic cell therapy (allo-ACT) for relapsed chronic myelogenous leukemia (CML) refractory to buffy coat transfusions post-allogeneic bone marrow transplantation.
Bone marrow transplantation 1996;18(6):1153-6.
-
1996: Ben-Yehuda D; Krichevsky S; Caspi O; Rund D; Polliack A; Abeliovich D; Zelig O; Yahalom V; Paltiel O; Or R; Peretz T; Ben-Neriah S; Yehuda O; Rachmilewitz E A
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.
Blood 1996;88(11):4296-303.
-
1996: Ben-Yosef R; Braverman I; Saah D; Nagler R; Shohat S; Or R; Nagler A
Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL).
Bone marrow transplantation 1996;18(5):1017-9.
-
1996: Abdul-Hai A; Or R; Slavin S; Friedman G; Weiss L; Matsa D; Ben-Yehuda A
Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice.
Experimental hematology 1996;24(12):1416-22.
-
1996: Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
Bone marrow transplantation 1996;18(4):721-4.
-
1996: Or R; Elad S; Shpilberg O; Eldor A
Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients.
American journal of hematology 1996;53(1):46-8.
-
1996: Nagler A; Ilan Y; Varadi G; Kapelushnik J; Or R
In vivo CAMPATH-1 followed by T cell-depleted bone marrow transplantation: a potential new mode of therapy for hepatitis-associated severe aplastic anemia (SAA).
Bone marrow transplantation 1996;18(2):475-8.
-
1996: Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
Transplantation 1996;62(1):138-42.
-
1996: Lossos I S; Or R; Goldstein R H; Conner M W; Breuer R
Amelioration of bleomycin-induced pulmonary injury by cyclosporin A.
Experimental lung research 1996;22(3):337-49.
-
1996: Kapelushnik J; Verstandig A; Or R; Meretyk S; Drakos P; Naparstek E; Nagler A
Hydronephrosis in children after bone marrow transplantation: case reports.
Bone marrow transplantation 1996;17(5):873-5.
-
1996: Slavin S; Naparstek E; Nagler A; Kapelushnik Y; Ackerstein A; Or R
Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT.
Blood 1996;87(9):4011-3.
-
1996: Or R; Nagler A; Shpilberg O; Elad S; Naparstek E; Kapelushnik J; Cass Y; Gillis S; Chetrit A; Slavin S; Eldor A
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.
Transplantation 1996;61(7):1067-71.
-
1996: Slavin S; Naparstek E; Nagler A; Ackerstein A; Samuel S; Kapelushnik J; Brautbar C; Or R
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
Blood 1996;87(6):2195-204.
-
1996: Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel A A; Yefenof E
Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Bone marrow transplantation 1996;17(2):237-41.
-
1996: Engelhard D; Elishoov H; Strauss N; Naparstek E; Nagler A; Simhon A; Raveh D; Slavin S; Or R
Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study.
Transplantation 1996;61(3):430-4.
-
1996: Toren A; Or R; Kapelushnik J; Chividalli G; Aku M; Slavin S; Nagler A
Normalization of serum lactic dehydrogenase in beta-thalassemia patients following bone marrow transplantation.
American journal of hematology 1996;51(2):166-7.
-
1996: Abeliovich D; Yehuda O; Nagler A; Lerer I; Ben-Neriah S; Amar A; Or R
Predominant 45,X,--Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis.
Cancer genetics and cytogenetics 1996;86(1):1-7.
-
1996: Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Clinical transplants 1996;():281-90.
-
1995: Varadi G; Or R; Rund D; Orbach H; Slavin S; Nagler A
Severe migratory polyarthritis following in vivo CAMPATH-1G.
Bone marrow transplantation 1995;16(6):843-5.
-
1995: Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Experimental hematology 1995;23(14):1553-62.
-
1995: Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
Elevated inflammatory cytokine levels in bone marrow graft rejection.
Transplantation 1995;60(9):943-8.
-
1995: Engelhard D; Elishoov H; Or R; Naparstek E; Nagler A; Strauss N; Cividalli G; Aker M; Ramu N; Simhon A
Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study.
Bone marrow transplantation 1995;16(4):565-70.
-
1995: Kapelushnik J; Or R; Filon D; Nagler A; Cividalli G; Aker M; Naparstek E; Slavin S; Oppenheim A
Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation.
Blood 1995;86(8):3241-6.
-
1995: Varadi G; Lossos A; Or R; Kapelushnik J; Nagler A
Successful allogeneic bone marrow transplantation in a patient with ATRA-induced pseudotumor cerebri.
American journal of hematology 1995;50(2):147-8.
-
1995: Lossos I S; Breuer R; Or R; Strauss N; Elishoov H; Naparstek E; Aker M; Nagler A; Moses A E; Shapiro M
Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study.
Transplantation 1995;60(7):672-8.
-
1995: Kapelushnik J; Or R; Delukina M; Nagler A; Livni N; Engelhard D
Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation.
Journal of pediatric gastroenterology and nutrition 1995;21(1):110-2.
-
1995: Delukina M; Kapelushnik Y; Or R; Naparstek E; Slavin S; Nagler A
Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP).
Medical oncology (Northwood, London, England) 1995;12(2):125-7.
-
1995: Berman E; Kapelushnik J; Sharon I; Or R; Atlan H; Nagler A
Assessment of proton magnetic resonance spectroscopy of blood serum as a diagnostic tool in bone marrow transplantation.
Medical oncology (Northwood, London, England) 1995;12(2):109-14.
-
1995: Kapelushnik J; Engelhard D; Mehta J; Or R; Brandstetter Y; Picard E; Cividalli G; Nagler A
Sequential respiratory syncytial virus and cytomegalovirus pneumonia following bone marrow transplantation.
Journal of medical virology 1995;46(2):169-71.
-
1995: Naparstek E; Or R; Nagler A; Cividalli G; Engelhard D; Aker M; Gimon Z; Manny N; Sacks T; Tochner Z
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
British journal of haematology 1995;89(3):506-15.
-
1995: Moses A E; Leibergal M; Rahav G; Perouansky M; Or R; Shapiro M
Aeromonas hydrophila myonecrosis accompanying mucormycosis five years after bone marrow transplantation.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1995;14(3):237-40.
-
1995: Nagler A; Ilan Y; Adler R; Or R; Naparstek E; Shouval D; Slavin S
Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination.
Bone marrow transplantation 1995;15(3):475-8.
-
1995: Chaushu G; Itzkovitz-Chaushu S; Yefenof E; Slavin S; Or R; Garfunkel A A
A longitudinal follow-up of salivary secretion in bone marrow transplant patients.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 1995;79(2):164-9.
-
1995: Abdul-Hai A; Lorberboum-Gliski H; Mechushtan A; Weiss L; Slavin S; Or R
Involvement of interleukin-2 in immunologic reconstitution following bone marrow transplantation in mice.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(1):95-101.
-
1995: Breuer R; Lossos I S; Or R; Krymsky M; Dagan A; Yedgar S
Abatement of bleomycin-induced pulmonary injury by cell-impermeable inhibitor of phospholipase A2.
Life sciences 1995;57(16):PL237-40.
-
1994: Chaushu S; Chaushu G; Garfunkel A; Slavin S; Or R; Yefenof E
Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following transplantation of T cell-depleted bone marrow.
Bone marrow transplantation 1994;14(6):925-8.
-
1994: Chaushu S; Chaushu G; Garfunkel A A; Slavin S; Or R; Yefenof E
Salivary immunoglobulins in recipients of bone marrow grafts. I. A longitudinal follow-up.
Bone marrow transplantation 1994;14(6):871-6.
-
1994: Nevo S; Drakos P; Goldenhersh M A; Zlotogorski A; Or R; Naparstek E; Nagler A
Generalized granuloma annulare post autologous bone marrow transplantation in a Hodgkin's disease patient.
Bone marrow transplantation 1994;14(4):631-3.
-
1994: Abeliovich D; Yehuda O; Ben-Neriah S; Or R
Loss of Y chromosome. An age-related event or a cytogenetic marker of a malignant clone?
Cancer genetics and cytogenetics 1994;76(1):70-1.
-
1994: Ilan Y; Nagler A; Shouval D; Ackerstein A; Or R; Kapelushnik J; Adler R; Slavin S
Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors.
Clinical and experimental immunology 1994;97(2):299-302.
-
1994: Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(4):245-8.
-
1994: Saah D; Drakos P E; Elidan J; Braverman I; Or R; Nagler A
Rhinocerebral aspergillosis in patients undergoing bone marrow transplantation.
The Annals of otology, rhinology, and laryngology 1994;103(4 Pt 1):306-10.
-
1994: Mehta J; Singhal S; Or R
Cyclophosphamide-induced cardiomyopathy during bone marrow transplantation for severe aplastic anemia.
The Journal of the Association of Physicians of India 1994;42(2):159-60.
-
1994: Or R; Mehta J; Kapelushnik J; Aker M; Naparstek E; Nagler A; Cividalli G; Slavin S
Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejection.
Bone marrow transplantation 1994;13(1):97-9.
-
1994: Safadi R; Or R; Bar Ziv J; Polliack A
Lymphoma-associated pancreatitis as a presenting manifestation of immunoblastic lymphoma.
Leukemia & lymphoma 1994;12(3-4):317-9.
-
1994: Nagler A; Elishoov H; Kapelushnik Y; Breuer R; Or R; Engelhard D
Cytomegalovirus pneumonia prior to engraftment following T-cell depleted bone marrow transplantation.
Medical oncology (Northwood, London, England) 1994;11(3-4):127-32.
-
1993: Breuer R; Lossos I S; Berkman N; Or R
Pulmonary complications of bone marrow transplantation.
Respiratory medicine 1993;87(8):571-9.
-
1993: Drakos P E; Nagler A; Or R; Naparstek E; Kapelushnik J; Engelhard D; Rahav G; Ne'emean D; Slavin S
Invasive fungal sinusitis in patients undergoing bone marrow transplantation.
Bone marrow transplantation 1993;12(3):203-8.
-
1993: Loewenthal E; Weiss L; Samuel S; Or R; Slavin S
Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1).
Bone marrow transplantation 1993;12(2):109-13.
-
1993: Ilan Y; Nagler A; Adler R; Naparstek E; Or R; Slavin S; Brautbar C; Shouval D
Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation.
Hepatology (Baltimore, Md.) 1993;18(2):246-52.
-
1993: Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Transplantation proceedings 1993;25(3):2375-6.
-
1993: Drakos P; Weinberger M; Delukina M; Or R; Nagler A; Weinberg M [corrected to Weinberger M ]
Inappropriate antidiuretic hormone secretion (SIADH) preceding skin manifestations of disseminated varicella zoster virus infection post-BMT.
Bone marrow transplantation 1993;11(5):407-8.
-
1993: Engelhard D; Naparstek E; Or R; Nagler A; Jacobs J; Shahar M B; Hardan I; Baciu H; Raveh D; Slavin S
Ganciclovir for the treatment of disseminated CMV disease without pneumonia in allogeneic T-lymphocyte depleted bone marrow transplantation.
Leukemia & lymphoma 1993;10(1-2):143-6.
-
1993: Mehta J; Nagler A; Ackerstein A; Kapelushnik J; Or R
Cutaneous hypersensitivity to co-trimoxazole after autologus bone marrow transplantation and immunotherapy with interferon alpha-2A and interleukin-2.
The Journal of the Association of Physicians of India 1993;41(4):235-6.
-
1993: Nageris B; Or R; Hardan I; Polliack A
Sudden onset deafness as a presenting manifestation of chronic lymphocytic leukemia.
Leukemia & lymphoma 1993;9(3):269-71.
-
1993: Nagler A; Mumcuoglu M; Naparstek E; Or R; Gan S; Slavin S
Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth.
Leukemia research 1993;17(1):61-7.
-
1993: Slavin S; Weiss L; Ackerstein A; Vourka-Karussis U; Morecki S; Or R; Nagler A; Kapelushnik J; Delukina M; Drakos P
Prevention and treatment of relapse by bone marrow transplantation.
Bone marrow transplantation 1993;12 Suppl 3():S54-6.
-
1992: Slavin S; Or R; Kapelushnik Y; Drakos P; Ackerstein A; Vourka-Karussis U; Weiss L; Nagler A
Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 4():164-6.
-
1992: Or R; Mehta J; Naparstek E; Okon E; Cividalli G; Slavin S
Successful T cell-depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmacytomas.
Bone marrow transplantation 1992;10(4):381-2.
-
1992: Samuel S; Nagler A; Or R; Slavin S
Effects of interleukin 2 on engraftment following autologous bone marrow transplantation (ABMT) in dogs.
Leukemia research 1992;16(10):967-72.
-
1992: Naparstek E; Hardan Y; Ben-Shahar M; Nagler A; Or R; Mumcuoglu M; Weiss L; Samuel S; Slavin S
Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Blood 1992;80(7):1673-8.
-
1992: Drakos P E; Nagler A; Or R; Gillis S; Slavin S; Eldor A
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation.
Cancer 1992;70(7):1895-8.
-
1992: Or R; Mehta J; Nagler A; Craciun I
Neutropenic enterocolitis associated with autologous bone marrow transplantation.
Bone marrow transplantation 1992;9(5):383-5.
-
1992: Konijn A M; Kaplan R; Or R; Matzner Y
Glycosylated serum ferritin in patients with hematological malignancies before and after bone marrow transplantation.
Leukemia & lymphoma 1992;7(1-2):151-6.
-
1992: Breuer R; Tochner Z; Conner M W; Nimrod A; Gorecki M; Or R; Slavin S
Superoxide dismutase inhibits radiation-induced lung injury in hamsters.
Lung 1992;170(1):19-29.
-
1992: Slavin S; Ackerstein A; Weiss L; Nagler A; Or R; Naparstek E
Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines.
Cancer investigation 1992;10(3):221-7.
-
1991: Engelhard D; Handsher R; Naparstek E; Hardan I; Strauss N; Aker M; Or R; Baciu H; Slavin S
Immune response to polio vaccination in bone marrow transplant recipients.
Bone marrow transplantation 1991;8(4):295-300.
-
1991: Slavin S; Ackerstein A; Vourka-Karussis U; Nagler A; Or R; Naparstek E; Weiss L
Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation.
Baillière's clinical haematology 1991;4(3):715-25.
-
1991: Or R; Naparstek E; Mani N; Slavin S
Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation. Two case reports with successful response to plasmapheresis.
Transplant international : official journal of the European Society for Organ Transplantation 1991;4(2):99-102.
-
1991: Berkman N; Michaeli Y; Or R; Eldor A
EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature.
American journal of hematology 1991;36(3):195-201.
-
1991: Slavin S; Ackerstein A; Kedar E; Reich S; Gomez S; Naparstek E; Nagler A; Or R; Weiss L
Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation.
Transplantation proceedings 1991;23(1 Pt 1):802-3.
-
1990: Slavin S; Ackerstein A; Naparstek E; Or R; Weiss L
The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?
Bone marrow transplantation 1990;6(3):155-61.
-
1990: Weshler Z; Breuer R; Or R; Naparstek E; Pfeffer M R; Lowental E; Slavin S
Interstitial pneumonitis after total body irradiation: effect of partial lung shielding.
British journal of haematology 1990;74(1):61-4.
-
1990: Slavin S; Eckerstein A; Hardan I; Ben Shahar M; Or R; Naparstek E; Weiss L
Toward improvement of therapeutic strategies in leukemia by amplification of the immune responses against leukemia.
Haematology and blood transfusion 1990;33():36-40.
-
1989: Bromiker R; Korman S H; Or R; Hardan I; Naparstek E; Cohen P; Ben-Shahar M; Engelhard D
Severe giardiasis in two patients undergoing bone marrow transplantation.
Bone marrow transplantation 1989;4(6):701-3.
-
1989: Engelhard D; Aker M; Or R; Shinar E
Combined therapy with granulocyte transfusion, intravenous opsonins and antibiotics for overwhelming Pseudomonas aeruginosa septicemia in neutropenic cancer patients.
The Pediatric infectious disease journal 1989;8(5):332-4.
-
1989: Slavin S; Naparstek E; Aker M; Cividalli G; Engelhard D; Hardan Y; Bromiker R; Brautbar C; Weshler Z; Or R
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders.
Transplantation proceedings 1989;21(1 Pt 3):3053-4.
-
1989: Engelhard D; Or R; Strauss N; Morag A; Aker M; Naparstek E; Breuer R; Ravid Z; Sarov I; Lijovetzky G
Cytomegalovirus infection and disease after T cell depleted allogeneic bone marrow transplantation for malignant hematologic diseases.
Transplantation proceedings 1989;21(1 Pt 3):3101-2.
-
1989: Ben-Yehuda A; Ben-Yehuda-Salz D; Or R; Landau E H; Krausz M M
Intestinal obstruction caused by bezoar: a rare complication after bone marrow transplantation.
Bone marrow transplantation 1989;4(1):137-8.
-
1989: Or R; Naparstek E; Aker M; Cividalli G; Engelhard D; Brautbar C; Weshler Z; Weiss L; Mumcuoglu M; Rachmilewitz E A
Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major.
Progress in clinical and biological research 1989;309():217-22.
-
1988: Breuer R; Or R; Lijovetzky G; Naparstek E; Engelhard D; Lafair J; Weshler Z; Slavin S
Interstitial pneumonitis in T cell-depleted bone marrow transplantation.
Bone marrow transplantation 1988;3(6):625-30.
-
1988: Engelhard D; Or R; Naparstek E; Leibovici V
Treatment with itraconazole of widespread tinea corporis due to Trichophyton rubrum in a bone marrow transplant recipient.
Bone marrow transplantation 1988;3(5):517-9.
-
1988: Yehuda A B; Or R; Naparstek E; Slavin S; Polliack A
T-cell depleted bone marrow transplantation for plasma cell myeloma. Report of a case and review of the results of BMT for myeloma.
Blut 1988;56(5):229-31.
-
1988: Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Israel journal of medical sciences 1988;24(3):145-50.
-
1988: Kedar E; Or R; Naparstek E; Zeira E; Slavin S
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
Bone marrow transplantation 1988;3(2):129-40.
-
1988: Or R; Naparstek E; Cividalli G; Aker M; Engelhard D; Slavin S; Rachmilewitz E A
Bone marrow transplantation in beta-thalassemia major. The Israeli experience.
Hemoglobin 1988;12(5-6):609-14.
-
1987: Gazitt Y; Or R; Mumcuoglu M; Slavin S
Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cells.
Bone marrow transplantation 1987;2(4):427-33.
-
1987: Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Transplantation proceedings 1987;19(1 Pt 3):2614-5.
-
1986: Polliack A; Gurfel D; Or R; Leizerowitz R; Gazitt Y
Hairy cell leukaemia: effects of phorbol ester on cell morphology and adherence and comparison with other B-cell neoplasias.
Scandinavian journal of haematology 1986;36(4):358-66.
-
1986: Slavin S; Or R; Naparstek E; Cividalli G; Weshler Z; Weiss L; Mumcuoglu M; Engelhard D; Aker M; Pollack A
New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation.
Israel journal of medical sciences 1986;22(3-4):264-7.
-
1984: Waldmann H; Polliak A; Hale G; Or R; Cividalli G; Weiss L; Weshler Z; Samuel S; Manor D; Brautbar C
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).
Lancet 1984;2(8401):483-6.
-
1984: Ben-Bassat H; Anor E; Penchas S; Shlomai Z; Prokocimer M; Or R; Polliack A
Concanavalin A receptors on the surface membrane of lymphocytes from patients with acute leukemia.
Leukemia research 1984;8(4):745-52.
-
1981: Polliack A; Prokocimer M; Or R; Korkesh A; Leizerowitz R; Ben-Bassat H; Gamliel H
Use of multiparameter studies and scanning electron microscopy in the interpretation and attempted correlation of surface morphology with cell type in 135 cases of human leukemias.
Cancer research 1981;41(3):1171-9.
Sign-in to see more